References
- Tsakiridis I, Giouleka S, Mamopoulos A, et al. Diagnosis and management of gestational diabetes mellitus: an overview of national and international guidelines. Obstet Gynecol Surv. 2021;76:367–381. doi:10.1097/OGX.0000000000000899
- Gao C, Sun X, Lu L, et al. Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis. J Diabetes Invest. 2019;10:154–162. doi:10.1111/jdi.12854
- Dugalic S, Petronijevic M, Vasiljevic B, et al. Trends of the prevalence of pre-gestational diabetes in 2030 and 2050 in Belgrade cohort. Int J Environ Res Public Health. 2022;19:6517. doi:10.3390/ijerph19116517
- Vambergue A, Nuttens MC, Goeusse P, et al. Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. Eur J Obstet Gyn R B. 2002;102:31–35. doi:10.1016/s0301-2115(01)00556-5
- Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: isshp classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43. doi:10.1161/HYPERTENSIONAHA.117.10803
- Zhang J, Meikle S, Trumble A, et al. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22:203–212. doi:10.1081/PRG-120021066
- McElwain CJ, Tuboly E, McCarthy FP, et al. Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health? Front Endocrinol. 2020;11:655. doi:10.3389/fendo.2020.00655
- Robillard PY, Dekker G, Iacobelli S, et al. An essay of reflection: why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology? J Reprod Immunol. 2016;114:44–47. doi:10.1016/j.jri.2015.07.001
- McCarthy FP, Ryan RM, Chappell LC. Prospective biomarkers in preterm preeclampsia: a review. Pregnancy Hypertens. 2018;14:72–78. doi:10.1016/j.preghy.2018.03.010
- Vieira MC, Begum S, Seed PT, et al. Gestational diabetes modifies the association between PlGF in early pregnancy and preeclampsia in women with obesity. Pregnancy Hypertens. 2018;13:267–272. doi:10.1016/j.preghy.2018.07.003
- Townsend R, Khalil A, Premakumar Y, et al. Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol. 2019;54:16–27. doi:10.1002/uog.20117
- Lim S, Li W, Kemper J, et al. Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis. Obstet Gynecol. 2021;137:72–81. doi:10.1097/AOG.0000000000004149
- SEQC Consortium. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the sequencing quality control consortium. Nat Biotechnol. 2014;32:903–914. doi:10.1038/nbt.2957
- Shi L, Reid LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006;24:1151–1161. doi:10.1038/nbt1239
- Omazić J, Viljetić B, Ivić V, et al. Early markers of gestational diabetes mellitus: what we know and which way forward? Biochemia Medica. 2021;31:030502. doi:10.11613/BM.2021.030502
- Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381. doi:10.1136/bmj.l2381
- Duck KA, Connor JR. Iron uptake and transport across physiological barriers. Biometals. 2016;29(4):573–591. doi:10.1007/s10534-016-9952-2
- Fisher AL, Nemeth E. Iron homeostasis during pregnancy. Am J Clin Nutr. 2017;106:1567S–1574S. doi:10.3945/ajcn.117.155812
- Xu MM, Wang J, Xie JX. Regulation of iron metabolism by hypoxia-inducible factors. Sheng Li Xue Bao. 2017;69:598–610. PMID: 29063108.
- Zhu S, Liu C, Zhao C, et al. Increased serum soluble transferrin receptor levels were associated with high prevalence of cardiovascular diseases: insights from the national health and nutrition examination survey 2017–2018. Front Cell Dev Biol. 2022;10:874846. doi:10.3389/fcell.2022.874846
- Zhu Y, Chen G, Bo Y, et al. Markers of iron status, blood pressure and incident hypertension among Chinese adults. Nutr Metab Cardiovasc Dis. 2019;29:830–836. doi:10.1016/j.numecd.2019.04.012
- Liu Z, Wang M, Zhang C, et al. Molecular functions of ceruloplasmin in metabolic disease pathology. Diabetes Metab Syndr Obes. 2022;15:695–711. doi:10.2147/DMSO.S346648
- Arenas de Larriva AP, Limia-Pérez L, Alcalá-Díaz JF, et al. Ceruloplasmin and coronary heart disease-A systematic review. Nutrients. 2020;12(10):3219. doi:10.3390/nu12103219
- Gao G, Li J, Zhang Y, et al. Cellular Iron Metabolism and Regulation. Adv Exp Med Biol. 2019;1173:21–32. doi:10.1007/978-981-13-9589-5_2
- Beharier O, Kajiwara K, Sadovsky Y. Ferroptosis, trophoblast lipotoxic damage, and adverse pregnancy outcome. Placenta. 2021;108:32–38. doi:10.1016/j.placenta.2021.03.007
- Ng SW, Norwitz SG, Norwitz ER. The impact of iron overload and ferroptosis on reproductive disorders in humans: implications for preeclampsia. Int J Mol Sci. 2019;20:13. doi:10.3390/ijms20133283
- Li M, Hou X, Zhang R, et al. Role of apolipoprotein E in suppressing oxidative stress in gestational diabetes mellitus patients and mouse model. Int J Gynaecol Obstet. 2022;159:204–212. doi:10.1002/ijgo.14076
- Sulistyowati S. The role of oxidative stress in the pathogenesis of pre-eclampsia. Pregnancy Hypertens. 2014;4:244. doi:10.1016/j.preghy.2014.04.014
- Belo L, Gaffney D, Caslake M, et al. Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies. Eur J Obstet Gyn R B. 2004;112:9–15. doi:10.1016/s0301-2115(03)00240-9
- Serrano NC, Guio-Mahecha E, Quintero-Lesmes DC, et al. Lipid profile, plasma apolipoproteins, and pre-eclampsia risk in the GenPE case-control study. Atherosclerosis. 2018;276:189–194. doi:10.1016/j.atherosclerosis.2018.05.051